{
    "items": [
        {
            "id": "_4l34qCmXZs",
            "title": "BIO Digital 2021 | A Conversation with Samsung Biologics from a CDMO Point of View",
            "description": "In case you missed it, you can now watch our on-demand BIO Digital 2021 session. Hear from Joon Y. Chang, our Senior Director of Global Sales and Operations Center, who shared insights on how Samsung Biologics delivers unique value to clients. \n\n#SamsungBiologics #BIODigital #BIO2021 #CDMO",
            "published_at": "2021-09-03 05:56:17"
        },
        {
            "id": "_EirLAWxz6g",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "_JSBiJnKp2o",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "_rw4A2s1XXs",
            "title": "Samsung Biologics Plant 4: Operational Excellence",
            "description": "https://samsungbiologics.com/\nWe have a proven track of reliability and world-class client satisfaction. Thanks to our focus on operational excellence, we're able to fulfill our clients' needs rapidly while maintaining a steady performance across all plants. Our Plant 4 is no exception. Soon to be the world's largest manufacturing facility at a single site, it will cement our position as one of biopharma's leading service providers.\n\n#Biologics #BioManufacturing #CDMO",
            "published_at": "2021-02-05 08:06:58"
        },
        {
            "id": "_TRvg7E6si8",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "-pif3TNMQZc",
            "title": "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì œ4ê³µì¥ \"ìˆ˜í¼í”ŒëœíŠ¸\"ë¥¼ ì†Œê°œí•©ë‹ˆë‹¤.",
            "description": "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì˜ ì œ 4ê³µì¥ì€ ë‹¨ì¼ ê³µì¥ ì„¸ê³„ ìµœëŒ€ ìƒì‚°ì˜ ê¸°ë¡ì„ ìì²´ ê²½ì‹ í•˜ê³  ì„¸í¬ì£¼ ê°œë°œë¶€í„° ì™„ì œ ìƒì‚°ê¹Œì§€ í•œ ê³µì¥ ì•ˆì—ì„œ One-stop Serviceê°€ ê°€ëŠ¥í•œ â€œìˆ˜í¼ í”ŒëœíŠ¸â€ë¡œ ì„¤ê³„ë˜ì—ˆìŠµë‹ˆë‹¤.\n\nì œ4ê³µì¥ì˜ ë¹„ì „ê³¼ íŠ¹ì¥ì ì„ ë¹„ë¡¯í•˜ì—¬ ì™„ê³µê¹Œì§€ì˜ ê±´ì„¤ ê³¼ì •ì„ ìƒìƒí•˜ê²Œ ì „ë‹¬í•˜ê¸° ìœ„í•´, Virtual Showroomì„ ì˜¤í”ˆí•˜ì˜€ìŠµë‹ˆë‹¤. \n\në°”ë¡œ ì§€ê¸ˆ ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì œ4ê³µì¥ Virtual Showroomì„ ë°©ë¬¸í•˜ì…”ì„œ ë°”ì´ì˜¤ ì—…ê³„ë¥¼ ì„ ë„í•˜ëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì˜ ë¯¸ë˜ë¥¼ í™•ì¸í•˜ì„¸ìš”.\n\nwww.samsungbiologics.com/plant4/kr",
            "published_at": "2020-12-03 11:43:37"
        },
        {
            "id": "007yIy_sQ60",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ê³µì •ê°œë°œ: ë°°ì–‘í¸",
            "description": "ë‹¨ì¼ ê³µì¥ ê¸°ì¤€ ì„¸ê³„ ìµœëŒ€ ë°”ì´ì˜¤ì˜ì•½í’ˆ ìƒì‚° ê·œëª¨ë¥¼ ìë‘í•˜ëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤!\në°”ì´ì˜¤ì˜ì•½í’ˆ ìƒì‚° í˜„ì¥ì—ì„œëŠ” ì–´ë–¤ ì¼ì„ í•˜ëŠ”ì§€ ê¶ê¸ˆí•˜ë‹¤ë©´?\nì¶œê·¼ë¶€í„° í‡´ê·¼ê¹Œì§€ ëœì„ ìœ¼ë¡œ ìƒì‚° ê·¼ë¬´ìì˜ í•˜ë£¨ë¥¼ ì²´í—˜í•´ë³´ì„¸ìš”!",
            "published_at": "2021-03-26 11:40:44"
        },
        {
            "id": "05WBOwOqnW0",
            "title": "Our Story : Driven. For Flexibility.",
            "description": "Since the emergence of the COVID-19 virus and other new life-threatening diseases, it is important for us to be as adaptable as possible in responding to the development and manufacturing needs of our clients. As a Senior Engineer on the Drug Product Operations team, Rahyun Park sees flexibility as an integral part of her job. Hear how being flexible allows her team to avoid risks, while creating an integrated drug product line.",
            "published_at": "2021-05-31 02:23:05"
        },
        {
            "id": "08I4Nn9_-WU",
            "title": "Resilient and Sustainable Eco-system of Biotherapeutics",
            "description": "Samsung Biologics is headquartered in Incheon, Korea, a globally-competitive biocluster, delivering biopharmaceuticals to more than 25 countries. As the leading CDMO, we drive innovation to deliver resilient and sustainable supply chain eco-system together with our global suppliers.\nTo learn more about our unique strengths, please follow our channel or visit our website at www.samsungbiologics.com",
            "published_at": "2020-07-16 08:41:46"
        },
        {
            "id": "0ByvOK9W8B8",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ê³µì •/ê°œë°œ : Quality í¸",
            "description": "ê³ ê°ì‚¬ì˜ ë°”ì´ì˜¤ì˜ì•½í’ˆì´ GMP ê·œê²©ì„ ì¤€ìˆ˜í•˜ì—¬ ì˜ ìƒì‚° ë˜ì—ˆëŠ”ì§€ íŒë‹¨í•˜ëŠ” ì‹œí—˜ë²•ë“¤ì„ ë§¤ì˜ ëˆˆìœ¼ë¡œ ê²€ì¦í•˜ëŠ” CMC(Chemistry, Manufacturing and Controls) QualityíŒ€. ëª¨ë“  í…ŒìŠ¤íŠ¸ê°€ í™˜ìì˜ ìƒëª…ê³¼ ì§ê²°ë˜ì—ˆë‹¤ëŠ” ë§ˆìŒê°€ì§ìœ¼ë¡œ ë§¤ì¼ì˜ ì—…ë¬´ì— ì„í•˜ëŠ” CMC QualityíŒ€ ìœ„ì°½í›ˆ í”„ë¡œì˜ í•˜ë£¨ë¥¼ ì†Œê°œí•©ë‹ˆë‹¤!",
            "published_at": "2021-09-30 10:25:04"
        },
        {
            "id": "0gZTAdbbcc8",
            "title": "[Full] CPhI WW 2019 | Speaker Session #2 | Cell Culture Manufacturing",
            "description": "This presentation provides tactical and strategic initiatives to maximize capacity utilization with a new large scale biologics manufacturing facility.",
            "published_at": "2019-11-07 14:41:05"
        },
        {
            "id": "1lsZztw9GJg",
            "title": "Season's Greetings from Samsung Biologics",
            "description": "In these extraordinary times, we are thankful for you and your continued support. We, at Samsung Biologics, wish you a happy holiday season and a prosperous New Year in 2021.",
            "published_at": "2020-12-24 07:03:31"
        },
        {
            "id": "1MomtGU-3ns",
            "title": "The Speed of Science",
            "description": "Samsung Biologics thrives on delivering life-saving solutions and quality biomedicines. In this new #NaturesBuildingBlocks series, produced by BBC StoryWorks, we show how we, as a leading global CDMO, rose to the challenge, matching the speed and scale of the pandemic to provide solutions and save lives.",
            "published_at": "2021-06-23 09:03:49"
        },
        {
            "id": "1VWOKpk_rD0",
            "title": "Understanding the Alleged Samsung Biologics Accounting Issue [Episode 3]",
            "description": null,
            "published_at": "2019-05-10 04:16:05"
        },
        {
            "id": "2ATdZr9uIjY",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "2Pnigq-uwnM",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ ê²½ì˜ì§€ì›: Salesí¸",
            "description": "ì‹ ê·œ ê³ ê°ì‚¬ë¥¼ ë°œêµ´í•˜ê³  ìœ ì¹˜í•˜ê¸° ìœ„í•´ ê¸€ë¡œë²Œí•œ ë‚˜ë‚ ì„ ë³´ë‚´ëŠ” SalesíŒ€!\nì„±ê³µì ì¸ ìˆ˜ì£¼ë¥¼ ìœ„í•´ì„œëŠ” ëŠì„ì—†ëŠ” ì»¤ë®¤ë‹ˆì¼€ì´ì…˜ì´ í•„ìˆ˜ì ì´ë¼ê³  í•˜ëŠ”ë°ìš”, Sales 2 ê·¸ë£¹ ì´ì—°ì„­ í”„ë¡œì˜ í•˜ë£¨ë¥¼ í†µí•´ ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì—ì„œì˜ ìˆ˜ì£¼ ì˜ì—… ì—…ë¬´ë¥¼ ì‚´í´ë´…ë‹ˆë‹¤.",
            "published_at": "2021-06-02 09:04:24"
        },
        {
            "id": "3ZFySPeXrkQ",
            "title": "How COVID-19 is Redefining Drug Development & Manufacturing | Festival of Biologics",
            "description": "Unprecedented challenging time also provides opportunities for a great advancement of innovation with cooperation. In this session, learn about\n- Close collaboration and communication with all stakeholders, utilizing the latest technology, establishing a robust business contingency plan, and eliminating a lead time to deliver drugs on time stably\n- Accelerate timelines by streamlining the process\n- Few case studies of our innovation to deliver drugs in just 3 months and how Samsung Biologics goes the extra mile",
            "published_at": "2021-04-15 04:20:52"
        },
        {
            "id": "4eDTF4vaBfE",
            "title": "How we expedite supply of COVID-19 Vaccines",
            "description": "As a fully integrated CDMO, we are committed to helping our clients provide quality treatments and vaccines to all those in need around the world. Through speed, quality and efficiency, we are working tirelessly to expedite the supply of COVID-19 vaccines using the latest innovative technology, multi-scale capacities, and reliable supply chain networks.",
            "published_at": "2021-07-13 09:10:05"
        },
        {
            "id": "5b9Nk2al9o0",
            "title": "End-to-end CDMO Service | Tools, Technologies, and Scientific Insights",
            "description": null,
            "published_at": "2021-06-10 07:59:21"
        },
        {
            "id": "6dQRJSh2Kog",
            "title": "Our Story: Driven. For Client Satisfaction.",
            "description": "Whether promoting the companyâ€™s future Plant 4 capabilities or how our teams use their advanced expertise to seamlessly meet every need, our Global Sales Operations Center introduces clients to the end-to-end, innovative services we offer. But their ultimate focus is satisfaction. As a Sales Group Leader, Peter Lee discusses how our integrated business model can unlock the potential and value in every part of the client experience.\n\n#SamsungBiologics #ClientSatisfaction #DrivenForLife",
            "published_at": "2021-04-20 02:18:43"
        },
        {
            "id": "76GpVEpunTQ",
            "title": "Samsung Biologics Plant 4: Construction Strengths",
            "description": "https://samsungbiologics.com/\nLeveraging our in-house engineering, procurement, and validation experience, Plant 4 is our most ambitious project to date. This facility will optimize our strengths, including speed, project management, and flexibility, to the fullest potential to better serve our clients.\n\n#Biologics #BioManufacturing #CDMO",
            "published_at": "2021-02-10 04:16:07"
        },
        {
            "id": "79ZPNt_O5BA",
            "title": "Samsung Biologics | 10 Years Strong",
            "description": "Ten years ago, we started with a singular vision: to enrich people's lives through technology and innovation. Since then, we've achieved exponential growth and delivered breakthrough innovations, creating an impact around the world. Driven to discover, develop, and manufacture breakthrough solutions to save livesâ€”we commemorate this day and look forward to the next decade to come.\n\nVisit our website to download the 10th Anniversary brochure where you can discover all we've accomplished and see what we have in store for the future.\n\n#SamsungBiologics #10YearsStrong #DrivenForLife #CDMO",
            "published_at": "2021-04-21 10:31:13"
        },
        {
            "id": "7bXxmKrp-L0",
            "title": "Continued Technical Innovation for Client Satisfaction",
            "description": "As an innovation-driven CDMO, our mission is to continuously better our strengths with our clients first in mind. At Samsung Biologics, we incorporate unique approaches to technology and facility design to maximize production flexibility and productivity to meet our client's needs.\n\nTo learn more about our innovative approaches, please follow our channel or visit us at www.samsungbiologics.com",
            "published_at": "2020-07-26 15:20:24"
        },
        {
            "id": "7vqTygQaitw",
            "title": "Introducing Biosafety Testing at Samsung Biologics",
            "description": "Comprehensive and precise, our Biosafety Testing service can support you in reaching your milestones, ensuring on-time, high-quality delivery to patients worldwide. As a one-stop CDMO partner, we do all testing in-house resulting in stable product releases for sample traveling, while maintaining a client-driven approach to provide superior levels of biosafety testing through close communication and 24/7 accessibility. \n\n#SamsungBiologics #CDMO #DrivenForLife #BiosafetyTesting",
            "published_at": "2021-09-07 02:09:35"
        },
        {
            "id": "80y-YoP2VtQ",
            "title": "Seahee Kim | Principal Scientist in Cell Line Development",
            "description": "Our Principal Scientist Seahee Kim describes her calm but steadfast approach to managing projects step by step - just like her mentor, another woman leader in the industry. Wrapping up this #WomensHistoryMonth, hear more from Seahee in this video clip and learn how she is making history at Samsung Biologics.",
            "published_at": "2020-03-31 11:51:38"
        },
        {
            "id": "8fREo2qAGsc",
            "title": "BIO Digital 2020 | BioProcess Insider Interview",
            "description": "Kevin Sharp, Senior Director of Business Development at Samsung Biologics, sat down with Bioprocess Insider editor Dan Stanton to discuss the company's agile response to the COVID-19 pandemic, the evolving role of the outsourcing manufacturing organization, and their future expansion plans.",
            "published_at": "2020-12-10 01:05:45"
        },
        {
            "id": "8qZDzaZD8FU",
            "title": "Benefits and Amenities at Samsung Biologics | People Matter",
            "description": "Life at Samsung Biologics is more than just work. We value people and that is our way of doing business. We are committed to building a better and healthier world for all.\n\nIf you want to know more about us, visit our website: https://www.samsungbiologics.com",
            "published_at": "2019-09-06 06:07:50"
        },
        {
            "id": "8x7wV67iu_s",
            "title": "Samsung Biologics Virtual Exhibition",
            "description": "Please visit: https://exhibition.samsungbiologics.com \n\nSamsung Biologics introduces a Virtual Exhibition site to provide a unique and convenient digital experience. In response to the industry-wide shift to virtual conferences, Samsung Biologics has taken a further step by providing an innovative, virtualized conference experience offering convenience for clients and industry professionals interested in learning more about the company and its services. \n\nVirtual Exhibition Hall visitors are first welcomed into a reception area where they can become oriented with the platform. The visitors can then digitally explore three main halls (CMO, CDO, CRO) that showcase the companyâ€™s capabilities and service offerings with informative video clips and interactive content. A Resource Library is also available to access additional information or schedule one-on-one meetings. The Samsung Biologics Virtual Exhibition Hall is highly intuitive, and optimized for both desktop and mobile devices and leverages a global cloud infrastructure to ensure speed and accessibility for users from any worldwide location.",
            "published_at": "2020-06-12 08:21:21"
        },
        {
            "id": "9iJoYm090V8",
            "title": "Samsung Biologics | Our Vision, 10 Years in the Making",
            "description": "A decade of dedication. For a future of infinite possibilities. \n\n#SamsungBiologics #DrivenForLife #CDMO #10YearsStrong",
            "published_at": "2021-04-30 07:47:42"
        },
        {
            "id": "A_kfco735UI",
            "title": "Samsung Biologics | Supply Chain Management",
            "description": "In light of the COVID-19 pandemic, building a resilient supply chain is now more important than ever. At Samsung Biologics, we believe maintaining stable supply and meeting the evolving needs of clients is key to securing steady business continuity. Please watch the video and learn from Kyoung Lim, Senior Director of Supply Chain Management at Samsung Biologics, on how we manage our robust supply chain management to prepare for any unprecedented crisis.",
            "published_at": "2020-11-12 08:40:43"
        },
        {
            "id": "a2Ytprnu_BI",
            "title": "Drug Product Manufacturing: Unmatched Throughput & Flexibility",
            "description": "With a high production capacity, client-first mindset, reliable track record, and expedited batch release, our Drug Product Manufacturing and Aseptic Fill-Finish Capability are unmatched in throughput and flexibility. Connect with us to learn more about our end-to-end CDMO services.",
            "published_at": "2021-05-07 09:44:18"
        },
        {
            "id": "aHEMENhqs1g",
            "title": "Samsung Biologics 3P Innovation",
            "description": "What is\" Better Life\"? At Samsung Biologics, we explore this question every day as part of our innovation principles. By continuously innovating our People, Process and Portfolio, we will fulfill our vision to become the most trusted partner to our clients working together to achieve a \"Better Life\" for humanity through biomedicines with innovation and technology. To learn more, visit our website at www.samsungbiologics.com #BetterLife",
            "published_at": "2020-06-26 05:20:19"
        },
        {
            "id": "asagHUnxB9c",
            "title": "Driven. For Life.",
            "description": "We are determined and resolute in our purpose: to be always dynamic, always responsible, and always innovative. It's in our DNA and itâ€™s a part of who we are.\nThis isnâ€™t just a jobâ€”itâ€™s a calling weâ€™ve dedicated our lives to. At Samsung Biologics, we're constantly inspired and driven to enrich human lives. \n\n#DrivenForLife",
            "published_at": "2021-01-28 09:13:51"
        },
        {
            "id": "AXWZ4PkWAH8",
            "title": "Quality Control_Microbiology Testing",
            "description": "ì§ë¬´ë¡œ ì•Œì•„ë³´ëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤_3.ë¯¸ìƒë¬¼ ë¶„ì„í¸\n\nSamsung Biologics Explained by Expert : 3.Quality Control\n\nIf you want to know more about us, visit our website: https://www.samsungbiologics.com",
            "published_at": "2018-04-02 12:39:48"
        },
        {
            "id": "BeLeUPI2jXI",
            "title": "[KR] BlueBetterFly \"Shaping the Future of Pharma\" Event (EU)",
            "description": "BlueBetterFly. í•˜ë‚˜ì˜ ì‘ì€ ë‚ ê°œì§“ì´ ë¯¸ë˜ì˜ í° ë³€í™”ë¥¼ ê°€ì ¸ì˜¬ ìˆ˜ ìˆë‹¤ëŠ” ìš°ë¦¬ì˜ ì‹ ë…ì„ ë³´ì—¬ì£¼ëŠ” 'Shaping the Future of Pharma' ë²„ì¶”ì–¼ ë„¤íŠ¸ì›Œí‚¹ í¬ëŸ¼ì—ì„œëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì™€ í•¨ê»˜ ì œì•½ ë°”ì´ì˜¤ ì—…ê³„ì˜ ì£¼ìš” ì „ë¬¸ê°€ë“¤ì˜ COVID-19 ê´€ë ¨ ê²¬í•´ë¥¼ ì²­ì·¨í•  ìˆ˜ ìˆëŠ” ê¸°íšŒë¥¼ ê°€ì¡ŒìŠµë‹ˆë‹¤. ì˜ìƒì„ í†µí•´ í™•ì¸ ë°”ëë‹ˆë‹¤.",
            "published_at": "2020-12-07 10:16:44"
        },
        {
            "id": "bjASuoReeuY",
            "title": "[Highlights] CPhI WW 2019 | Speaker Session #2 | Cell Culture Manufacturing",
            "description": "This presentation provides tactical and strategic initiatives to maximize capacity utilization with a new large scale biologics manufacturing facility.",
            "published_at": "2019-11-07 14:49:05"
        },
        {
            "id": "BJMLqRNvwRM",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "bM2hjdKE5xM",
            "title": "Small Scale Manufacturing Capabilities at Samsung Biologics",
            "description": "At Samsung Biologics, our goal is to satisfy clients of varying sizes and needs. This week we celebrated the mechanical completion of our single-use mammalian cell culture drug substance facility with 1K bioreactor designed to produce clinical to commercial drugs. This new facility is expected to be cGMP ready in 2Q 2020 and provide greater process flexibility while continuing to maintain our world-class reliability and quality.",
            "published_at": "2019-12-13 05:39:10"
        },
        {
            "id": "C4z8TFn1IMs",
            "title": "Accelerated Tech Transfer from Development to Manufacturing for a COVID-19 Program | BPI West",
            "description": "The devastating effects wrought by the COVID-19 pandemic can only be mitigated by the rapid development and manufacture of vaccines and neutralizing antibodies. However, tech transfer remains a critical, time-consuming step on the path towards large-scale production of therapeutics in such times of crisis. Here we describe the acceleration of tech transfer to enable kickoff to vial thaw for antibody manufacture within three months for a clinical program and within five months for a process qualification campaign. We demonstrate various approaches to reduce the timeline from development to manufacturing at a 15kL scale. We also discuss the implications of this work towards enabling a rapid response to future pandemics, as well as introducing routine accelerated tech transfer to our site.",
            "published_at": "2021-04-16 05:02:29"
        },
        {
            "id": "D8N9yqn1xPo",
            "title": "Samsung Biologics | Better Future for Humanity",
            "description": "At Samsung Biologics, we envision building a better future together with our clients. This vision is what drives us to empower breakthroughs to help patients all around the globe. With our leading expertise and capabilities, Samsung Biologics promises to give our clients endless opportunities and potential that give lasting impact to bring the future we all want to live in.\n\nTo learn more about our promises, follow our channel or visit us at www.samsungbiologics.com",
            "published_at": "2020-08-03 02:31:19"
        },
        {
            "id": "DCiNgFAhwuI",
            "title": "Our Story: Driven. For Inclusion.",
            "description": "For #InternationalWomensMonth, we're celebrating the remarkable footsteps women have made in global health while recognizing what we do to create an equal workplace. In our employee spotlight series, hear how Eri Kwon, a senior scientist and member of our Bio Women's Club, is helping to build an inclusive environment and better life for all.  #IWD2021 #ChoosetoChallenge",
            "published_at": "2021-03-19 05:09:34"
        },
        {
            "id": "dKoXclRycF8",
            "title": "Key Considerations in Choosing Stainless Steel vs Single Use Bioprocessing",
            "description": "This presentation will introduce the current competing market between Stainless Steel and Single Use Systems, with a further in-depth analysis of the capabilities and benefits of stainless steel systems. In this presentation, Justin Carbungco, our Group Leader of Manufacturing Operations, will also look into the lessons learned regarding the affect of the COVID-19 pandemic on manufacturing with stainless steel and single use systems.",
            "published_at": "2021-06-28 08:29:58"
        },
        {
            "id": "dPzDybFsUOs",
            "title": "Navigating the CDMO Market: Hurdles, Transformation & Opportunities",
            "description": "Watch our webinar from CPhI Discover 2021 where Kevin Sharp, Head of Alliance Management, discusses the key factors and challenges shaping the future of the CDMO market as well as what innovation will look like post-COVID-19. \n\n#SamsungBiologics #CDMO #CPhIdiscover",
            "published_at": "2021-05-31 09:02:17"
        },
        {
            "id": "EacWY-NWwTs",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ê³µì •ê°œë°œ: CDOê°œë°œí¸",
            "description": "ë°”ì´ì˜¤ì˜ì•½í’ˆì˜ ì²« ì—¬ì •ì´ ë˜ëŠ” ìœ„íƒê°œë°œ(CDO)!\nì„¸í¬ì£¼ ê°œë°œë¶€í„° ì„ìƒ í—ˆê°€ê¹Œì§€ ì±…ì„ì§€ëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ CDOê°œë°œíŒ€ì—ì„œì˜ í•˜ë£¨ë¥¼ ì†Œê°œí•©ë‹ˆë‹¤!",
            "published_at": "2021-03-29 10:49:58"
        },
        {
            "id": "eL_PQ53kp54",
            "title": "Successful Approval With Process Characterization & Validation",
            "description": "On your path to commercialization, we provide a robust, risk-mitigated approach at every touchpoint to scale up your manufacturing efficiency from process characterization to process validation and beyond.\n\n#SamsungBiologics #CDMO #DrivenForLife",
            "published_at": "2021-09-17 05:58:18"
        },
        {
            "id": "F7nc8MAixxg",
            "title": "SBA SF R&D Center Tour",
            "description": null,
            "published_at": "2021-04-23 03:16:22"
        },
        {
            "id": "FbScLHr35nI",
            "title": "Largest Capacity at a Single Site",
            "description": "As your most reliable and flexible CDMO Partner, every day we continue to innovate our facility and supply network to ensure we meet all client and industry needs.  \n\nSamsung Biologics is currently the world's largest CMO service provider at a single site making the fastest growth track-records in the industry, reaching patients all around the globe. \n\nOver the next 3 weeks, we will present an in-depth series into the unique values of Samsung Biologics and the service offerings it provides. \n\nTo learn more, please follow our channel or visit our website at www.samsungbiologics.com",
            "published_at": "2020-07-03 12:36:25"
        },
        {
            "id": "FFT0sULwkqU",
            "title": "BMWS 2020 | Quality Digital Transformation",
            "description": "How do we use digitalization to evolve the current standards to improve quality, productivity, and regulatory processes while offering an unparalleled client experience? Learn more from our SVP & Chief Quality Officer Sam MacHour who shared Samsung Biologics' vision for the future at this year's Biomanufacturing World Summit.",
            "published_at": "2020-12-04 07:07:57"
        },
        {
            "id": "FMx1dEcL-7k",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "FoRRc8xbjfc",
            "title": "Business Continuity Through Supply Chain Management",
            "description": null,
            "published_at": "2021-03-10 09:06:48"
        },
        {
            "id": "FpPaLSu7WJU",
            "title": "BIO Digital 2020 | Securing Your Manufacturing Capacity During the Pandemic",
            "description": "In this BIO Digital 2020 presentation, Richard Lee, Head of DP at Samsung Biologics, talks about the importance of securing a secondary source to your pharmaceutical supply chain in a post-COVID era, and how Samsung Biologics is successfully coping with the global pandemic to ensure the safety of our employees as well as our client campaigns.",
            "published_at": "2020-12-10 00:53:40"
        },
        {
            "id": "gN4msAp2bzE",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "GrnXvIShTnc",
            "title": "Life at Samsung Biologics | Celebrating Lunar New Year",
            "description": "Celebrating Lunar New Year in the traditional Korean attire \"Hanbok,\" our employees talk about embracing a new culture and how Samsung Biologics brings #BetterLife to their journey.",
            "published_at": "2020-01-23 10:17:39"
        },
        {
            "id": "Gsx_JM8_k68",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ê³µì •ê°œë°œ: MSATí¸",
            "description": "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì˜ ê³µì • ê¸°ìˆ ì„ ë‹´ë‹¹í•˜ëŠ” MSAT(Manufacturing, Science and Technology)íŒ€,\nê³ ê°ì‚¬ì˜ ê³µì • ê¸°ìˆ ì„ ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì— ë§ë„ë¡ ì´ì „í•˜ê³ , ê³µì • ì „ëµì„ ì§œëŠ” ì—…ë¬´ì¸ ë§Œí¼\nê³ ê°ì‚¬ì™€ëŠ” ë¬¼ë¡  ìœ ê´€ ë¶€ì„œì™€ì˜ ì»¤ë®¤ë‹ˆì¼€ì´ì…˜ì´ ì¼ìƒì¸ë°ìš”,\ní˜‘ì—…ê³¼ í˜‘ì—…, ê·¸ë¦¬ê³  ë˜ í˜‘ì—…ìœ¼ë¡œ ì™„ì„±ë˜ëŠ” MSATíŒ€ì˜ í•˜ë£¨ë¥¼ ì‚´í´ë´…ë‹ˆë‹¤~",
            "published_at": "2021-03-29 10:50:18"
        },
        {
            "id": "H-mxK5yzMrk",
            "title": "Jo Beth DeFreitas | Principal Specialist & Team Leader in QA",
            "description": "Jo Beth DeFreitas, our QA Team Leader, was most influenced by a past co-worker who coached her when she started her first job fresh out of school, almost 20 years ago. Just as how she was helped by another woman in building her career, Jo Beth enjoys mentoring and helping others to see their success and exceed their own expectations. Hear more about how she is shaping history at Samsung Biologics in this video clip. #WomensHistoryMonth",
            "published_at": "2020-03-31 10:45:31"
        },
        {
            "id": "h02N86cRPpw",
            "title": "Samsung Biologicsâ€™ Virtual Exhibition Hall wins Best Digital Campaign award",
            "description": "Samsung Biologics' Virtual Exhibition Hall won the Best Digital Campaign award for its ingenuity and creativity in the biopharma space during Digital Pharma Innovation Week. It was recognized for its highly interactive digital capabilities and virtual reality (VR) technology to connect with clients around the world. Blending realistic details from the Company's existing VIP exhibition room and physical facilities, the advanced solution allows users to explore its CDO, CMO, and CRO services from any device, anywhere in the world.",
            "published_at": "2020-11-25 07:43:15"
        },
        {
            "id": "HBngVoqQlPY",
            "title": "Samsung Biologics launched its proprietary cell line, S-CHOice.",
            "description": "S-CHOice builds on glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line technology and shows improved titers up to two-fold from industry average, reaching above 7 g/L for standard monoclonal antibodies. The cell line also shows enhanced cell viability with over 90% at day-21 in a fed-batch study, demonstrating effectiveness in producing high-quality cell lines.\n\nCheck out how our new proprietary cell line, S-CHOice, allows us to serve our CDO clients in bringing their molecule faster and better to market and ultimately into the hands of patients.",
            "published_at": "2020-08-18 08:57:21"
        },
        {
            "id": "HDnTvs9DQj0",
            "title": "#ë•ë¶„ì—ì±Œë¦°ì§€ \"ì˜ë£Œì§„ ì—¬ëŸ¬ë¶„, ê°ì‚¬í•©ë‹ˆë‹¤ ê·¸ë¦¬ê³  ì¡´ê²½í•©ë‹ˆë‹¤\" - ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ | Thanks to Challenge - Samsung Biologics",
            "description": "ì½”ë¡œë‚˜19ì˜ ìµœì „ì„ ì—ì„œ ì‹¸ìš°ê³  ìˆëŠ” ëª¨ë“  ì˜ë£Œì§„ë“¤ì„ ìœ„í•´â™¥\n#ë•ë¶„ì—ì±Œë¦°ì§€ \n\nì½”ë¡œë‚˜19ê°€ ì¥ê¸°í™”ë˜ë©´ì„œ ëª¨ë“  ì´ë“¤ì—ê²Œ í˜ê²¨ìš´ ì‹œê°„ì´ ì§€ì†ë˜ê³  ìˆìŠµë‹ˆë‹¤.\nì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ëŠ” ì˜ë£Œì§„ ì—¬ëŸ¬ë¶„ë“¤ì˜ í—Œì‹ ê³¼ ë…¸ê³ ì— ì§„ì‹¬ìœ¼ë¡œ ê°ì‚¬ë“œë¦¬ë©°, ì–´ë ¤ì›€ì„ ê·¹ë³µí•˜ê³  ê³„ì‹  ëª¨ë“  ë¶„ë“¤ì—ê²Œ ìœ„ë¡œì™€ ì‘ì›ì˜ ë§ˆìŒì„ ì „ë‹¬í•˜ê³ ì í•©ë‹ˆë‹¤.\n\nì–´ë ¤ìš´ í™˜ê²½ì—ì„œë„ ê¸€ë¡œë²Œ ë¹„ì¦ˆë‹ˆìŠ¤ êµë¥˜ì— í˜ì“°ëŠ” ì¸ì²œê²½ì œììœ êµ¬ì—­ì²­(IFEZ)ì— ì¢‹ì€ ëœ»ì„ í•¨ê»˜ ì´ì–´ê°ˆ ë™ì°¸ì˜ ì˜ì§€ë¥¼ ì „í•©ë‹ˆë‹¤. \n#ë•ë¶„ì—ì±Œë¦°ì§€ #ì˜ë£Œì§„ë•ë¶„ì— #ë•ë¶„ì—ìº í˜ì¸\n\nTo all doctors, nurses and medical workers at the forefront of the country's fight against COVID-19, thank you. \n\nThese are challenging and stressful times for everyone.\nAt Samsung Biologics, we are deeply thankful for the continued hard work, dedication and professionalism of the front-line contributors who are working tirelessly to tackle COVID-19 crisis.\n\nWe will continue to offer our full support in improving society's health and wellness to fight this together. \n\nSamsung Biologics passes on this honor to IFEZ (Incheon Free Economic Zone Authority) to participate in this giving thanks relay. \n\nTo learn more about the latest ways Samsung Biologics is responding to COVID-19, visit our website at https://samsungbiologics.com/front/en/mediaCenter/covid19_resources.do",
            "published_at": "2020-08-18 02:04:14"
        },
        {
            "id": "hj_qTjZo2dI",
            "title": "[Full] CPhI WW 2019 | Speaker Session #3 | Selecting The Right CDMO",
            "description": "This presentation describes considerations for CDMO selection to help determine the right partner. Samsung Biologics' fully integrated CDMO capabilities including product development, manufacturing and testing services with focus on client partnerships to accelerate timelines whilst providing quality services and solutions. Samsung Biologics' partnership model provides flexibility to meet client requirements for phase appropriate manufacturing and testing and builds on a successful track record.",
            "published_at": "2019-11-08 06:06:11"
        },
        {
            "id": "hPIefBiCQ8g",
            "title": "Dennis Lee - Lead Scientist in the QC Team at Samsung Biologics",
            "description": "Dennis Lee is a Lead Scientist in the QC team at Samsung Biologics. \"My personal goal is to take every opportunity to learn, grow, and take on new challenges.\" Hear his story about working at Samsung Biologics, and enter our Talent Pool at https://www.samsungbiologics.com",
            "published_at": "2019-07-05 06:42:05"
        },
        {
            "id": "hXgIhxLACnw",
            "title": "Interview with The Korea Society: Vaccine Cooperation",
            "description": "Demand for bio-medicines in a rapidly changing global environment is increasing day by day. Amid growing global interest in the COVID-19 vaccine as a critical key to ending the pandemic, Samsung Biologics drew attention from both the media and the industry for its recent agreement for the fill-finish manufacturing of Modernaâ€™s COVID-19 vaccine.\n \nRecently, John Rim, CEO of Samsung Biologics, had an interview with Thomas Byrne, President and CEO of The Korea Society, a nonprofit organization that aims to promote greater awareness, mutual understanding, and cooperation between the U.S. and South Korea.\n\nThe Korea Societyâ€™s â€œPresident's Interview Seriesâ€ particularly explores the economic, financial, and business relations between South Korea and the U.S. In addition to sharing the current outlook of the pharmaceutical industry, CEO John Rim discussed Samsung Biologics' capabilities to manufacture mRNA vaccines, its role in the ongoing pandemic as a leading global CDMO, and its future growth vision.\n\nTo watch the full interview, please click on the video below.\n\n#SamsungBiologics #DrivenForLife #COVID #vaccines",
            "published_at": "2021-07-21 23:00:27"
        },
        {
            "id": "I_SDf4Ip1do",
            "title": "Enhanced Project Management, At Your Service",
            "description": "To support your development journey faster and better, we make it our goal to enhance client communication every step of the way with our flexible, real-time, secured Project Management Service (PMS). We are ready to offer optimized quality and productivity for your development project throughout the entire operational process. To learn more about our service, please connect with our team today.\nhttps://samsungbiologics.com/contact-us",
            "published_at": "2021-04-28 00:45:05"
        },
        {
            "id": "I2O6CRQ3NKc",
            "title": "Samsung Biologics BOD Interview | Eunice Kim",
            "description": "Eunice Kim is an outside director at Samsung Biologics appointed at the company's 2020 Annual General Shareholder's Meeting. A tenured law professor and a certified lawyer with an extensive working background, Ms. Kim shares her internal & external director experience from previous years along with her expectations on strengthening Samsung Biologics' internal controls and compliance.",
            "published_at": "2020-05-15 08:14:39"
        },
        {
            "id": "i7iXzf5354o",
            "title": "Samsung Biologics CDO & CRO",
            "description": "Samsung Biologics CDO Team is happy to present our CDO & CRO introduction video! \n\nWe deliver your success to IND & BLA Faster & Better, with maximum flexibility to our valuable partners. \n\nWe promise the Best. \n\n#SamsungBiologics #CDO #FasterandBetter",
            "published_at": "2020-03-12 07:39:55"
        },
        {
            "id": "iFVCz5fz2Vs",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "iL8uEdtyumQ",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "IrWP-34ZWGU",
            "title": "Continuous Manufacturing Technology to Existing Process | American Biomanufacturing Summit",
            "description": "Watch our webinar from the American Biomanufacturing Summit where Thomas Gervais, PhD, our Head of Manufacturing Sciences and Technology, discusses key considerations and challenges in implementing N-1 perfusion technology as well as the impact of continuous technology on tech transfer and process scale-up.",
            "published_at": "2021-05-17 08:15:12"
        },
        {
            "id": "j1VFJZMsBbE",
            "title": "BIO Digital 2020 | The Evolving Role of the Outsourcing Manufacturer",
            "description": "In this round-table discussion, Daniel Slone, VP & Head of Downstream Manufacturing at Samsung Biologics, talks with other industry figures on how far the biopharma industry has embraced the technologies and methodologies of manufacturing 4.0.",
            "published_at": "2020-12-09 08:44:56"
        },
        {
            "id": "JBQuYKCe_eE",
            "title": "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì°½ë¦½ 10ì£¼ë…„ ê¸°ë… ì´ë²¤íŠ¸ | 'ë„ˆì—ê²Œ ê½ƒì„ ë³´ë‚¸ë‹¤'",
            "description": "ì°½ë¦½ 10ì£¼ë…„ X ì‚¬ë‚´ì‘ê°€ë‹¨\n'ë„ˆì—ê²Œ ê½ƒì„ ë³´ë‚¸ë‹¤'\n\nì°½ë¦½ 10ì£¼ë…„ì„ ê¸°ë…í•´, \nì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì‚¬ë‚´ì‘ê°€ë‹¨ì´ íŠ¹ë³„í•œ 'ë§ˆìŒ ì „ë‹¬ ì´ë²¤íŠ¸'ë¥¼ ì¤€ë¹„í–ˆìŠµë‹ˆë‹¤.\n\nê°ì‚¬í•œ ë§ˆìŒ, ì†Œì¤‘í•œ ë§ˆìŒ, ì‘ì›ì˜ ë§ˆìŒì„ ë‹´ì€\në™ë£Œì˜ ë©”ì‹œì§€ì™€ ê¹œì§ ì„ ë¬¼ ë•ë¶„ì—, \n\nì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì„ì§ì›ë“¤ì˜ ë§ˆìŒì—ë„ \nì›ƒìŒê½ƒì´ í™œì§ í•€ í•˜ë£¨ì˜€ìŠµë‹ˆë‹¤. :D ğŸ’",
            "published_at": "2021-04-29 10:01:44"
        },
        {
            "id": "JEMQipE5HMI",
            "title": "Innov-daptation: Shifting Challenges to Opportunity in Bio Manufacturing | Next Pharma (Next NORMAL)",
            "description": "A key strategy for achieving a successful biomanufacturing business highly depends on agile operation and transparency across the value chain. Preparing for digital transformation in advance can eliminate possible risks when faced with unexpected crises. Samsung Biologics quickly enabled innov-daptation (digital transformation) to overcome various challenges amid the pandemic. In this session, learn more about Samsung Biologicsâ€™ innovative efforts of digital transformation to enhance data integrity and process innovation to achieve client satisfaction.",
            "published_at": "2021-04-12 08:39:21"
        },
        {
            "id": "JH4m2v07ahM",
            "title": "Samsung Biologics Global Internship Recruitment",
            "description": "The Samsung Biologics Global Internship program is designed to provide direct and hands-on work experience for those interested in pursuing a career in the bio industry. Check out how our interns have transformed, growing as future leaders of an up-and-coming industry. To learn more, visit our website https://bit.ly/39eZ7fv \n\n#BetterLife by Samsung Biologics.",
            "published_at": "2020-03-02 07:58:37"
        },
        {
            "id": "JNiu6eYwJtM",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "jWwjke_0EIw",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ê³µì •/ê°œë°œ : PM í¸",
            "description": "ê¸°ìˆ ì´ì „ë¶€í„° ìƒì‚°, í—ˆê°€ê¹Œì§€ í†µí•©ê´€ë¦¬í•˜ëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ PM (Project Management)íŒ€. PM ì§ë¬´ì˜ ì¼ê³¼ì™€ í•„ìˆ˜ ì—­ëŸ‰ê¹Œì§€ ì•Œì°¨ê²Œ ì „í•˜ëŠ” PMíŒ€ ê¹€ìˆ˜ë¯¼ í”„ë¡œì˜ í•˜ë£¨ë¥¼ ë§Œë‚˜ë³´ì„¸ìš”!",
            "published_at": "2021-04-27 06:48:19"
        },
        {
            "id": "KAMEC4z-svU",
            "title": "BIO Digital 2020 | Get to IND Faster: Accelerated & High Performance Cell Line Development",
            "description": "Expediting a development timeline is directly related to obtaining IND clearance and starting your Phase 1 Study faster. At BIO Digital 2020, John Gill, Director of Cell Line Development at Samsung Biologics, describes how you can get to IND faster through our accelerated & high-performance proprietary cell line, S-CHOice. In addition, we present the combined benefit with S-CHOice and a two-step purification platform, which can further expedite the timeline and reduce manufacturing costs.\nOur CDO services provide a full scope of development to help our clients reach IND from cell line development, process development, to non-clinical and clinical material manufacturing.",
            "published_at": "2020-12-08 06:35:07"
        },
        {
            "id": "Kq7wxLal7EQ",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "KqKah31Q6aM",
            "title": "Samsung Biologics' San Francisco CDO R&D Center Grand Opening",
            "description": "Samsung Biologics' San Francisco CDO R&D Center is finally opened in October, 2020. \nAs your nextdoor CDO partner, we now provide faster & better development service for your success to IND & BLA with maximum flexibility.\n\nContact : cdo.business@samsung.com",
            "published_at": "2020-11-11 00:52:56"
        },
        {
            "id": "kuDovv8KLpY",
            "title": "Samsung Biologics Plant 4 : Specs & Features",
            "description": "https://samsungbiologics.com/\nFrom large-scale manufacturing to smaller batch sizes, Plant 4 is our most flexible facility to date, with a diverse line-up of bioreactors to support clients' varying needs. Watch our video to explore these features, see how we've integrated cyber security and data integrity into our process, and more at a single site.\n\n#Biologics #BioManufacturing #CDMO",
            "published_at": "2021-02-10 04:15:59"
        },
        {
            "id": "LeT-V0Ry5CA",
            "title": "2021 DCAT Week: Building The Future With Samsung Biologics Plant 4",
            "description": "Watch our on-demand session from the virtual DCAT Member Company Announcement Forum where Segang Park, our Vice President of Engineering Project Management, EPCV, shared detailed insights about our Plant 4 expansion project.",
            "published_at": "2021-08-10 22:56:04"
        },
        {
            "id": "lPNT3Yt-Ac4",
            "title": "2021ë…„ í•˜ë°˜ê¸° ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì˜¨ë¼ì¸ ì±„ìš©ì„¤ëª…íšŒ â”‚ ëœì„ ì¡ë‹´(LANç·š JOBè«‡) ì‹œì¦Œ2",
            "description": "Driven. For Better Life, Better Work. \në” ë‚˜ì€, ë” ê±´ê°•í•œ ì¸ë¥˜ì˜ ì‚¶ì„ í–¥í•´ ëŠì„ì—†ì´ ë„ì „í•˜ëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤. \nì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì™€ í•¨ê»˜ ì¸ë¥˜ì˜ ë” ë‚˜ì€ ë‚´ì¼ì— ê¸°ì—¬í•˜ê³  ì‹¶ë‹¤ë©´?\n2021 í•˜ë°˜ê¸° ì˜¨ë¼ì¸ ì±„ìš©ì„¤ëª…íšŒ ì˜ìƒì„ ë†“ì¹˜ì§€ ë§ˆì„¸ìš”!\n\nâ€»ë³¸ ìë£ŒëŠ” ë‹¹ì‚¬ì˜ ìì‚°ì´ë¯€ë¡œ, í•´ë‹¹ ì˜ìƒì˜ ìº¡ì²˜/ì´¬ì˜/ë…¹í™” ë° ë¶ˆë²• ê³µìœ ë¥¼ ê¸ˆí•©ë‹ˆë‹¤.",
            "published_at": "2021-09-09 00:38:33"
        },
        {
            "id": "lSG0sfeUUvw",
            "title": "A Day in The Life of a Samsung Biologics Intern",
            "description": "Interns play an integral role at Samsung Biologicsâ€”they're the innovators-to-be and the passionate newcomers who want to learn from the best while in turn, inspiring us to think outside the box. Our internship program offers a diverse array of learning experiences within various functions across the organization. Watch our video to get a glimpse of what a day looks like for our interns.",
            "published_at": "2020-07-30 09:39:00"
        },
        {
            "id": "lTm96fUvzxw",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ê³µì •/ê°œë°œ : ì •ì œí¸",
            "description": "ë°°ì–‘ ê³µì •ì—ì„œ ë‚˜ì˜¨ ë°”ì´ì˜¤ì˜ì•½í’ˆì˜ ì›ì•¡ì„ ì •ì œí•˜ê³ , ì•Œë§ì€ ë†ë„ë¡œ ë§ì¶”ì–´ ìµœì¢… DS(Drug Substance) ì›ì•¡ì„ ì œì¡°í•˜ëŠ” ì •ì œê·¸ë£¹. ì™„ì„±ëœ DSì›ì•¡ì€ í™˜ìì—ê²Œ íˆ¬ì—¬ë˜ì–´ ìƒëª…ì„ ì‚´ë¦¬ëŠ” ì•½ì´ê¸° ë•Œë¬¸ì— â€˜ì—…ë¬´â€™ê°€ ì•„ë‹ˆë¼ â€˜ì±…ì„â€™ì„ í•´ë‚´ê² ë‹¤ëŠ” ë§ˆìŒê°€ì§ìœ¼ë¡œ ì •ì œ ì—…ë¬´ì— ì„í•˜ëŠ” ì „ì§„ê´‘ í”„ë¡œì˜ í•˜ë£¨ë¥¼ ì†Œê°œí•©ë‹ˆë‹¤!",
            "published_at": "2021-10-06 08:18:39"
        },
        {
            "id": "ltNYyM5ky8E",
            "title": "[EN] BlueBetterFly \"Shaping the Future of Pharma\" Event (US)",
            "description": "BlueBetterFly. An experience completely unique to Samsung Biologics that encompasses our pride and belief that one small change can have a big impact on the future. In our \"Shaping the Future of Pharma\" virtual networking forum, we hosted a roundtable discussion on the impact of COVID-19 and offered attendees the opportunity to connect and share insights with distinguished industry professionals in the US on the future of biomanufacturing.",
            "published_at": "2020-12-07 09:57:24"
        },
        {
            "id": "LW7T48bWFl8",
            "title": "Webinar | Efficiency For Validation \"Continuous Change & Improvement\"",
            "description": "In case you missed it, you can now watch our PharmTech webinar. Hear from Ray Cox, our Senior Director of Quality Engineering, will shared insights on how implementing master protocols and risk-based approaches can make the validation process more efficient.",
            "published_at": "2021-09-09 08:17:42"
        },
        {
            "id": "lYPjHRTqUPc",
            "title": "[Full] CPhI WW 2019 | Speaker Session #1 | Drug Product",
            "description": "This presentation describes Samsung Biologicsâ€™ experience with Drug Product projects in clinical and commercial stages, with clientele ranging from virtual companies to big pharma. Within five years, Samsung Biologics has evolved from a single filling line start-up to an emerging competitor in the DP CDMO landscape. Focused on reinventing the customer experience, Samsung Biologics is determined to deliver where others cannot. Four case studies will be presented illustrating the adaptability and innovation Samsung Biologics has employed to successfully deliver a quality product and maintain their clientsâ€™ supply chains consistently and reliably.",
            "published_at": "2019-11-06 17:36:25"
        },
        {
            "id": "M0flZTWgawA",
            "title": "[Highlights] CPhI WW 2019 | Speaker Session #3 | Selecting The Right CDMO",
            "description": "This presentation describes considerations for CDMO selection to help determine the right partner. Samsung Biologics' fully integrated CDMO capabilities including product development, manufacturing and testing services with focus on client partnerships to accelerate timelines whilst providing quality services and solutions. Samsung Biologics' partnership model provides flexibility to meet client requirements for phase appropriate manufacturing and testing and builds on a successful track record.",
            "published_at": "2019-11-08 06:48:18"
        },
        {
            "id": "M5JWZ2PCZ0c",
            "title": "Adam Gibbons - Lead Engineer in the Aseptic Filling Team at Samsung Biologics",
            "description": "Adam Gibbons, Lead Engineer in the Aseptic Filling Team, is originally from Southern California. Find out how he's adjusting to his life at Samsung Biologics in this video. \n\nIf you want to know more about us, visit our website: https://www.samsungbiologics.com",
            "published_at": "2019-07-26 05:49:48"
        },
        {
            "id": "Mit_lwP_BKs",
            "title": "Bring Your Sequence. We'll Take You to IND.",
            "description": "With an exceptional track record in process and approvals, we merge quality and speed to get you to IND faster and better than anyone else.",
            "published_at": "2021-06-08 01:35:12"
        },
        {
            "id": "Mj4iVsr6Np0",
            "title": "Samsung Biologics | Regulatory Approvals from Global Agencies",
            "description": null,
            "published_at": "2021-05-21 04:57:55"
        },
        {
            "id": "MjFRMBsZAFg",
            "title": "Biopharmaceutical Process Characterization",
            "description": "Samsung Biologics presents its process development and characterization strategies required to support the commercial scale manufacturing of antibody therapeutics. In this webinar, we discuss how we develop a robust and scalable manufacturing process to support successful GMP manufacturing of biologics.",
            "published_at": "2020-06-24 10:03:50"
        },
        {
            "id": "MT7JhZmcg-0",
            "title": "Fast & Efficient Downstream Process Development with Two-step Purification Platform",
            "description": "To reduce manufacturing costs and shorten the development timeline, the biotech industry is increasingly considering the application of a two-step purification scheme. The presentation describes the two-step purification platform for monoclonal antibody production achieved through Samsung's accumulated state-of-the-art technology.",
            "published_at": "2020-10-29 08:27:23"
        },
        {
            "id": "n3kwYXIijSE",
            "title": "Better Life: We are all in this together",
            "description": "At Samsung Biologics, one thing is clear - we are devoted to our shared vision to make \"Better Life\" for all humanity and deliver life-saving drugs to the world. We are in this together as One Team.",
            "published_at": "2021-01-26 09:42:04"
        },
        {
            "id": "Nr5DP7kOAV8",
            "title": "Through S-CHOice Cell Line & 2-Step Purification Platform",
            "description": "Expediting the development timeline is directly related to obtaining IND clearance and starting the phase 1 study faster. This webinar describes how you can get to IND faster through our accelerated & high-performance proprietary cell line, S-CHOice. In addition, we present the combined benefit with S-CHOice and 2-step purification platform, which can further expedite the timeline and reduce manufacturing costs.\nOur CDO services provide a full scope of development to help our clients reach IND from cell line development, process development, to non-clinical and clinical material manufacturing.",
            "published_at": "2020-09-28 06:52:30"
        },
        {
            "id": "NX_CkhGuFuk",
            "title": "Project Management",
            "description": "ì§ë¬´ë¡œ ì•Œì•„ë³´ëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤_1.PMí¸\n\nSamsung Biologics Explained by Expert : 1.Project Management\n\nIf you want to know more about us, visit our website: https://www.samsungbiologics.com",
            "published_at": "2018-03-26 12:27:45"
        },
        {
            "id": "o0K5O3-lf_Q",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "O4gdDBp8KmQ",
            "title": "Our Story: Driven. For Quality.",
            "description": "At our company, we put quality at the center of everything we do so not only to satisfy our clients but also to meet regulatory standards and ensure successful cGMP manufacturing operations. In our employee spotlight series, Sonya Lee breaks down why quality and process improvement are so vital to our work, and how they make up a core element of Samsung Biologics' #DrivenForLife mission.",
            "published_at": "2021-03-26 11:49:23"
        },
        {
            "id": "oDnggV34hI0",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ê³µì •/ê°œë°œ : EPCVí¸",
            "description": "ì‹ ê·œ ê±´ì„¤ê³¼ ê¸°ì¡´ ê³µì¥ ê°œë³´ìˆ˜ì— ìˆì–´ ì¤‘ì¶”ì ì¸ ê°€êµ ì—­í• ì„ í•˜ëŠ” EPCV(Engineering, Procurement, Construction, Validation)ì„¼í„°, 4ê³µì¥ í”„ë¡œì íŠ¸ ì „ë°˜ì„ ê´€ë¦¬í•˜ê³  ìˆëŠ” EPMíŒ€ì˜ í•˜ë£¨ë¥¼ ì†Œê°œí•©ë‹ˆë‹¤!",
            "published_at": "2021-09-30 07:13:32"
        },
        {
            "id": "OH6AbQrK4j8",
            "title": "Samsung Biologics' Risk-Mitigated Biosafety Testing Webinar",
            "description": "Samsung Biologics' extensive biosafety testing is crucial in assessing the safety of all biological products both for clients and patients. In this webinar, we'll discuss our unique biosafety testing strategy that can help mitigate risks to meet our clients' diversifying needs, and ensure on-time delivery without sacrificing proven quality.\nOur CRO services provide a fully integrated on-site testing with great expertise in mycoplasma detection, adventitious virus testing and microbial testing services in benefit of well-established CMO services such as global standard QA service and 24/7 dedicated sample management group.",
            "published_at": "2020-07-14 01:39:46"
        },
        {
            "id": "P_va-99uKiU",
            "title": "2021 Samsung Biologics Annual General Meeting of Shareholders",
            "description": "Samsung Biologics held the Annual General Meeting of Shareholders on March 19, 2021. Despite the global uncertainties with the ongoing pandemic, Samsung Biologics demonstrated outstanding operational excellence and business agility even during such extraordinary circumstances.\n\nì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ëŠ” ì§€ë‚œ 3ì›” 19ì¼, ì œ 10íšŒ ì •ê¸°ì£¼ì£¼ì´íšŒë¥¼ ì§„í–‰í–ˆìŠµë‹ˆë‹¤. ì²˜ìŒìœ¼ë¡œ ì „ìíˆ¬í‘œë¥¼ ë„ì…í•œ ì´ë²ˆ ì£¼ì£¼ì´íšŒì—ëŠ” ì´ 100ì—¬ëª…ì˜ ì£¼ì£¼ê°€ í˜„ì¥ ë° ì˜¨ë¼ì¸ ì¤‘ê³„ë¡œ ì°¸ì„í•œ ê°€ìš´ë°, â–²ì¬ë¬´ì œí‘œ ìŠ¹ì¸ê³¼ â–²ì´ì‚¬ ë³´ìˆ˜í•œë„ ìŠ¹ì¸ ì•ˆê±´ì´ ëª¨ë‘ í†µê³¼ëìŠµë‹ˆë‹¤. ì¡´ë¦¼ ì‚¬ì¥ì€ \"ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ëŠ” 2021ë…„ ìƒˆë¡œìš´ ë¯¸ë˜ë¥¼ í–¥í•´ ê¸€ë¡œë²Œ ì¢…í•© ë°”ì´ì˜¤ ê¸°ì—…ìœ¼ë¡œ ë„ì•½í•˜ê¸° ìœ„í•œ ì¤€ë¹„ë¥¼ ë³¸ê²©ì ìœ¼ë¡œ ì‹œì‘í•˜ë ¤ í•œë‹¤\"ë©° â€œESG íˆ¬ì í™•ëŒ€ ë“±ì„ í†µí•´ ê±´ê°•í•˜ê³  íˆ¬ëª…ì„± ìˆëŠ” ì§€ì†ê°€ëŠ¥ê²½ì˜ ê¸°ì—…ì´ ë˜ê² ë‹¤\"ê³  ë°í˜”ìŠµë‹ˆë‹¤.",
            "published_at": "2021-03-26 12:05:39"
        },
        {
            "id": "P0JA1X9XypY",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "plLRNDaZ8hc",
            "title": "[EN] BlueBetterFly \"Shaping the Future of Pharma\" Event (EU)",
            "description": "BlueBetterFly. An experience completely unique to Samsung Biologics that encompasses our pride and belief that one small change can have a big impact on the future. In our \"Shaping the Future of Pharma\" virtual networking forum, we hosted a roundtable discussion on the impact of COVID-19 and offered attendees the opportunity to connect and share insights with distinguished industry professionals in the EU on the future of biomanufacturing.",
            "published_at": "2020-12-07 10:12:48"
        },
        {
            "id": "PoDJq6YeM-Q",
            "title": "COVID-19 ì‚¬íƒœë¡œ ë³¸ ë°±ì‹ ì˜ ë°œì „ê³¼ì •: ë‹¨ë°±ì§ˆ, í•µì‚° ê·¸ë¦¬ê³  ë°”ì´ëŸ¬ìŠ¤",
            "description": "ìµœê·¼ ì˜ì•½í’ˆì€ ì¦ìƒì„ ìœ ì§€ì‹œí‚¤ê±°ë‚˜ ë³‘ì„ ì¹˜ë£Œí•˜ê³  ì˜ˆë°©í•˜ê¸°ê¹Œì§€ ìš°ë¦¬ ì‚¶ì˜ ì§ˆì„ í¬ê²Œ í–¥ìƒì‹œì¼°ìŠµë‹ˆë‹¤. WHOê°€ ê·œëª…í•œ ì§ˆë³‘ Xë¡œ ì†Œì¶”ë˜ëŠ” í˜„ì¬ì˜ COVID-19 íŒ¬ë°ë¯¹ ìƒí™©ì—ì„œ ì ì¬ì ì¸ ì§ˆë³‘ì›ì„ ì°¾ëŠ” ê²ƒì€ ë”ìš± ì¤‘ìš”í•´ì¡ŒìŠµë‹ˆë‹¤. ì´ë¥¼ ìœ„í•´ì„œëŠ” ë‹¤ì–‘í•œ ë³‘ì›ê· ì— ë§ì„œëŠ” ë°±ì‹ ì„ ì ì‹œì— ìƒì‚°í•˜ëŠ” ë¯¼ì²©í•œ ì œì¡° ëŠ¥ë ¥ê³¼ ìœ ì—°í•œ í”Œë«í¼ì´ ìš”êµ¬ë©ë‹ˆë‹¤. ë¹„ë¡ ì „í†µì ì¸ ë°±ì‹ ì€ ìì—°ì ì¸ ë³‘ì›ê· ì— ë„ë¦¬ ì“°ì´ì§€ë§Œ, ì•ˆì •ì„± ê²€ì¦ì— ì‹œê°„ì´ ì†Œìš”ë©ë‹ˆë‹¤. ì§€ë‚œ 20ë…„ ê°„ ì¬ì¡°í•© ë‹¨ë°±ì§ˆ, í•µì‚°, ê·¸ë¦¬ê³  ë°”ì´ëŸ¬ìŠ¤ ìš´ë°˜ì ë“± ìƒˆë¡œìš´ ì„¸ëŒ€ì˜ ë°±ì‹ ì´ ê°œë°œë˜ì—ˆìŠµë‹ˆë‹¤. ì¸ë¥˜ì˜ ì•ˆì „ì´ ìµœìš°ì„ ìœ¼ë¡œ ì¬ê³ ë˜ëŠ” í˜„ íŒ¬ë°ë¯¹ ìƒí™©ì—ì„œ, ì‹¤í—˜ì ì¸ ì ‘ê·¼ì€ ì „í†µì ì¸ ë°±ì‹  í”Œë ›í¼ì—ì„œì˜ ê³ ì§ˆì ì¸ ì´ìŠˆë¥¼ ìµœì†Œí™”í•˜ê¸° ìœ„í•œ ì²¨ë‹¨ ê¸°ìˆ ì´ ë™ë°˜ë˜ì–´ì•¼ í•©ë‹ˆë‹¤.",
            "published_at": "2020-09-04 06:10:52"
        },
        {
            "id": "Pw9QB7Zp3iU",
            "title": "Samsung Biologics, the Most Reliable & Flexible CDMO Partner",
            "description": "As your most reliable and flexible CDMO partner, Samsung Biologics provides service offerings tailored to client and industry needs. In our enhanced & extended line of service, we leverage our business and sales efforts on small scale manufacturing and Asceptic filling in response to increasing demand. To find out more in detail, visit our website at www.samsungbiologics.com and get in touch.",
            "published_at": "2019-11-06 07:58:58"
        },
        {
            "id": "PwRPPqTXHgU",
            "title": "Samsung Biologics at CPhI Worldwide 2019 | Highlights",
            "description": "Samsung Biologics attended CPhI Worldwide 2019 in Frankfurt. With a newly branded booth, Samsung Biologics showcased a virtual tour of our facility and held great sessions with our lineup of speakers on Continuous Manufacturing, Aseptic Filling, and CDMO Selection. We are so grateful to everyone who showed so much interest in our fully integrated custom-tailored services and End-to-End CDMO capability.",
            "published_at": "2019-12-04 00:48:19"
        },
        {
            "id": "qMgxwdUaRI8",
            "title": "The Speed of Science (with ENG/KOR Subtitle)",
            "description": "In 2020, life was disrupted by the COVID-19 pandemic, and pharmaceutical companies faced the challenge of responding to a critical need for drug products globally. In this new #NaturesBuildingBlocks series, produced for us by BBC StoryWorks Commercial Productions, we show how as a CDMO, we rose to the challenge, matching the speed and scale of the pandemic to provide solutions and save lives.",
            "published_at": "2021-06-24 04:09:03"
        },
        {
            "id": "QmRQrfNvCVc",
            "title": "Every Action Counts. We are Driven. For Life.",
            "description": "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì„ì§ì›ì˜ ì‹œì„ ìœ¼ë¡œ ë‹´ì•„ë‚¸, ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì—ì„œì˜ ë¹›ë‚˜ëŠ” í•˜ë£¨!\n\në§¤ì¼ ë§¤ì¼ ëˆ„êµ°ê°€ì˜ ê°€ëŠ¥ì„±ê³¼ í¬ë§, ê·¸ë¦¬ê³  ì†Œì¤‘í•œ ë‚´ì¼ì„ ë§Œë“¤ì–´ë‚˜ê°„ë‹¤ëŠ” ê±´ ì–´ë–¤ ì˜ë¯¸ì¼ê¹Œìš”?\n\nê°ì í•˜ëŠ” ì¼ì€ ëª¨ë‘ ë‹¤ë¥´ì§€ë§Œ, ë” ê±´ê°•í•œ ì„¸ìƒì„ í–¥í•´ í•œë§ˆìŒìœ¼ë¡œ ë‚˜ì•„ê°€ê³  ìˆëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì„ì§ì›ë“¤ì˜ í•˜ë£¨ë¥¼ ì†Œê°œí•©ë‹ˆë‹¤!",
            "published_at": "2021-07-29 08:09:56"
        },
        {
            "id": "QXSyZ7_qpao",
            "title": "MSAT (Manufacturing Sciences and Technology)",
            "description": "ì§ë¬´ë¡œ ì•Œì•„ë³´ëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤_2.ê³µì •ê¸°ìˆ í¸\n\nSamsung Biologics Explained by Expert : 2.MSAT\n\nIf you want to know more about us, visit our website: https://www.samsungbiologics.com",
            "published_at": "2018-03-26 12:15:35"
        },
        {
            "id": "RAaxswVTmxk",
            "title": "The Mission & Pride | Our Work Saves Lives",
            "description": "At Samsung Biologics, our shared mission of creating a better life for all humanity is a source of pride for our employees. We believe the work we do every single day matters â€” giving hope and making a better tomorrow.",
            "published_at": "2020-09-11 07:45:19"
        },
        {
            "id": "rETDhVLcAQU",
            "title": "2020 ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ê¸€ë¡œë²Œ ì¸í„´ ì¼ê³¼ ì—¿ë³´ê¸°",
            "description": "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ê¸€ë¡œë²Œ ì¸í„´ì€ ì–´ë–¤ í•˜ë£¨ë¥¼ ë³´ë‚¼ê¹Œ?\n\ní•™êµìƒí™œê³¼ëŠ” ì°¨ì›ì´ ë‹¤ë¥¸ íšŒì‚¬ì—ì„œì˜ ìƒí™œ, \nì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì—ì„œ ì¸í„´ìƒí™œì˜ ê²½í—˜ì„ ìƒìƒí•˜ê²Œ ì „ë‹¬í•˜ëŠ”ë°ìš”.\n\nì„¸ê³„ë¡œ ë‚˜ì•„ê°€ëŠ” BIO ì¸ì¬ê°€ ë˜ê¸° ìœ„í•œ ê¸€ë¡œë²Œ ì¸í„´ì˜ í•˜ë£¨ë¥¼ ë§Œë‚˜BIO~\n\n#ì‚¼ì„± #ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ #ê¸€ë¡œë²Œì¸í„´ #ì¸í„´ì˜í•˜ë£¨",
            "published_at": "2020-08-28 09:20:14"
        },
        {
            "id": "rm6jHnZu8Ks",
            "title": "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì—°í•˜ì¥",
            "description": "ê·¸ ì–´ëŠ ë•Œë³´ë‹¤ ë„ì „ì ì´ê³  í˜ë“¤ì—ˆë˜ 2020ë…„ì„ ë˜ëŒì•„ë³´ë©°, ì˜¬ í•œ í•´ë„ ë³€í•¨ ì—†ëŠ” ì‹ ë¢°ë¡œ ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì™€ í•¨ê»˜í•´ ì£¼ì‹¬ì— ê°ì‚¬ë“œë¦½ë‹ˆë‹¤. ë‹¤ê°€ ì˜¬ 2021ë…„ì—ë„ ê±´ìŠ¹ê³¼ ë²ˆì˜ì´ ê°€ë“í•˜ì‹œê¸¸ ì§„ì‹¬ìœ¼ë¡œ ê¸°ì›í•˜ë©° ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì™€ í•¨ê»˜ í•  ë°ì€ ë¯¸ë˜ë¥¼ ê¸°ëŒ€í•©ë‹ˆë‹¤.",
            "published_at": "2020-12-24 07:04:21"
        },
        {
            "id": "rMWv2V2oo4g",
            "title": "Samsung Biologics Internship: Most Memorable Experiences",
            "description": "As an intern at Samsung Biologics, you'll gain real-world experience working alongside the most innovative thinkers and doers in the industry. From first impressions to memorable work experiences, hear from our interns as they share their unique stories and give advice for future applicants.",
            "published_at": "2021-02-02 08:56:16"
        },
        {
            "id": "rQFhwJMmp7I",
            "title": "Post-COVID 19 Multi-Sourcing Trend in Biomanufacturing",
            "description": "In this PHARMAP 2021 virtual session, Regina Choi-Rivera, our Vice President of Drug Product, discussed how Samsung Biologics works closely with our clients and regulatory agencies to guarantee a resilient supply of raw materials and deliver pharmaceutical medicines on time through a multi-sourcing strategy.",
            "published_at": "2021-07-20 07:36:57"
        },
        {
            "id": "rqTFV3K46Fo",
            "title": "BIO Digital 2020 | Economics of Stainless Steel and Single-Use Systems",
            "description": "With the development of single-use systems for biomanufacturing, the lingering question is â€œWhich system is better; Single-use or stainless steel?â€ For anyone that has looked into this topic, the answer is not black and white. In this BIO Digital 2020 presentation, Justin Carbungco, Associate Director of sCMO at Samsung Biologics, focuses on the cost comparisons for stainless steel and single-use systems, and some considerations for companies that are looking into clinical and contract manufacturing.",
            "published_at": "2020-12-08 06:37:49"
        },
        {
            "id": "RwPDVO8IfOQ",
            "title": "Understanding the Alleged Samsung Biologics Accounting Issue [Episode 1]",
            "description": "This is the first of a three part video series created by Samsung Biologics to aid in the understanding of the facts regarding the alleged accounting issue.",
            "published_at": "2019-05-09 06:35:50"
        },
        {
            "id": "SAgMc8twNTc",
            "title": "The Future of Biopharma: Plant 4",
            "description": "We are continuously pushing the boundaries to bring the success of our client's drug development and manufacturing journey. With our mission to build a healthier future for all, our new Plant 4 will merge innovative bioprocessing technology, automation, and digital capabilities with high-quality processes and multiple scales to ultimately accelerate our clients' life-saving treatments to patients in need.\n\n#SamsungBiologics #CDMO #DrivenForLife",
            "published_at": "2021-08-06 08:56:59"
        },
        {
            "id": "scMJyi3mjxs",
            "title": "Samsung Biologics' Proprietary Cell Line Launch Ceremony",
            "description": "As the world's leading CDMO company, Samsung Biologics has been making innovative moves. Today, we presented an official launch of Samsung Biologicsâ€™ proprietary cell line, a high-performing technology to start your successful therapeutics development journey.\n\nPresenter : \n- Eun Young Yang (VP, Head of CDO Business Team)\n- John Gill (Director, Head of Cell Line Development Part)\n\nContact: cdo.business@samsung.com",
            "published_at": "2020-08-05 00:15:18"
        },
        {
            "id": "SwgEzsxTVf0",
            "title": "S-CHOice : Accelerated, High-performing Cell Line Development",
            "description": "It can be a critical decision by any institution to\nselect the right host cell line; it can impact quality, cost of goods, and timeline. The presentation describes development studies of S-CHOice, Samsungâ€™s proprietary cell line, which can help achieve high-quality products, adding value to Samsungâ€™s one-stop CDMO capability.",
            "published_at": "2020-10-29 08:38:12"
        },
        {
            "id": "SwsVYFNINEI",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "T3Zl0adoyGk",
            "title": "[KR] 3D Scientific Video about CDO Process Development and Capability",
            "description": "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ CDO ì„œë¹„ìŠ¤ëŠ” ì„¸í¬ì£¼ ê°œë°œë¶€í„° ì„ìƒ ìƒì‚°ì— ì´ë¥´ê¸°ê¹Œì§€ CDO ê°œë°œì˜ ëª¨ë“  ë‹¨ê³„ì—ì„œ ë¹ ë¥´ê³  ë” ë‚˜ì€ ì„œë¹„ìŠ¤ë¥¼ ì œê³µí•©ë‹ˆë‹¤. ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ CDO ì„œë¹„ìŠ¤ë¥¼ í†µí•œ ì—¬ëŸ¬ë¶„ì˜ ë°”ì´ì˜¤ ì˜ì•½í’ˆ ê°œë°œ ì „ ê³¼ì •ì„ ì˜ìƒì„ í†µí•´ í™•ì¸í•´ ë³´ì„¸ìš”.",
            "published_at": "2020-12-29 07:07:44"
        },
        {
            "id": "t4XklGeRZ0M",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "tATir0onwNw",
            "title": "Accelerated High-performing Platform Process of Monoclonal Antibody | PEGS Boston",
            "description": "Accelerated High-performing Platform Process of Monoclonal Antibody: Upstream Optimization Case Study | PEGS Boston\n\nSelecting the right CDMO partner is critical for any institution as the decision can impact product quality, cost and timeline. This presentation will delve into the CDO Upstream Process at Samsung Biologics which helps customers achieve high quality products with accelerated timelines.",
            "published_at": "2021-05-17 10:47:00"
        },
        {
            "id": "tbaK_fVI79A",
            "title": "What to consider in selecting the best cell line to accelerate the timeline to IND | BPI West",
            "description": "The start of a biologicâ€™s developmental journey is represented with cell line development. During this exciting milestone, a suitable cell line must be selected for optimizing the remaining processes at the highest output. Where reducing time to market can determine a key factor for a successful business, selecting the right pathway from the start is critical to prevent any future risks. In this session, Samsung Biologics, as an integrated CDMO partner, will explain how we provide tailored solutions to suggest what to consider in selecting the best cell line to accelerate speed to market.",
            "published_at": "2021-04-16 05:05:11"
        },
        {
            "id": "tnfkiDY_omM",
            "title": "Operational Excellence for Client Satisfaction",
            "description": "At Samsung Biologics, we have a shared mission to provide optimal solutions that are tailored for our clients' needs. As an award-winning CDMO partner with numerous proven regulatory approvals, we are committed to delivering operational excellence through our unique technology and innovation to optimize client satisfaction.\n\nTo learn more about our operational excellence, please follow our channel or visit us at www.samsungbiologics.com",
            "published_at": "2020-08-03 00:02:59"
        },
        {
            "id": "TqjexX2dHMk",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ê³µì •/ê°œë°œ : DPê³µì •í¸",
            "description": "ì™„ì œ ì˜ì•½í’ˆ(DP: Drug Product)ì€ í™˜ìì—ê²Œ ìµœì¢…ì ìœ¼ë¡œ íˆ¬ì—¬ë  ìˆ˜ ìˆë„ë¡ ì¼ì •í•œ ì œí˜•ìœ¼ë¡œ ì œì¡°ëœ ì˜ì•½í’ˆìœ¼ë¡œ, ì™„ì œ ì˜ì•½í’ˆì„ ìƒì‚°í•˜ëŠ” ê³µì •ì€ ë”ìš± ì—„ê²©í•˜ê³  ê¹Œë‹¤ë¡œìš´ ê´€ë¦¬ê°€ í•„ìš”í•©ë‹ˆë‹¤. DPê³µì •íŒ€ì—ì„œëŠ” ì–´ë–¤ ì¼ì„ í•˜ëŠ”ì§€, ë‚˜ì˜ˆì§€ í”„ë¡œì˜ í•˜ë£¨ë¥¼ í†µí•´ ì•Œì•„ë´…ë‹ˆë‹¤!",
            "published_at": "2021-06-02 09:03:40"
        },
        {
            "id": "Tr2uX1XIRfI",
            "title": "Our Story: Driven. For Innovation.",
            "description": "In our Samsung Bio Story series, we highlight not only the life-changing work our people do but also their personal experiences and diverse perspectives. As a project manager for tech transfer at Samsung Biologics, Doo Hyun Kevin Ra's role involves careful planning, evaluation, and a bit of ingenuity to meet project timelines efficiently while maintaining high quality. Hear about how he and his colleagues shorten the tech transfer process from six to three months, and what being \"Driven. For Innovation.\" means to him.",
            "published_at": "2021-02-18 08:30:22"
        },
        {
            "id": "u7FeZILD5Nw",
            "title": "Our Story: Driven. For Digitalization.",
            "description": "During the pandemic, on-site regulatory and client inspections and tours became difficult to conduct. To solve this challenge, Seongil Choi, the head of IT-EDM, and his team implemented the Live Virtual Tour (LVT) solution to allow for global clients to access our facilities via a live-streaming platform and take a scheduled tour, audit, or inspection at their convenience. In this month's BIO Story segment, hear how Seongil and his team successfully utilized LVT and what \"Driven. For Life.\" means to him.\n\n#SamsungBiologics #CDMO #Digitalization #DrivenForLife #OurBIOStory",
            "published_at": "2021-07-29 02:01:53"
        },
        {
            "id": "UDNrKL4BGns",
            "title": "Our Business Continuity Management System",
            "description": "At a time where crisis management plays an increasingly greater role worldwide, we put client satisfaction as a top priority. Samsung Biologics has been operating under the Business Continuity Management System (BCMS) to act swiftly against unexpected incidents that may potentially disrupt our business. Through our analysis, design, implementation, and validation process, we are able to detect the risk of potential business disruptions, reduce supply interruptions, and operate in an efficient manner to become the most trusted partner to our clients.",
            "published_at": "2020-09-28 06:14:25"
        },
        {
            "id": "v2fB3n96F4o",
            "title": "BIO Digital 2020 | Key Considerations for a Successful Technology Transfer",
            "description": "Samsung Biologics is a fully integrated contract service provider offering services from mammalian cell line and process development to cGMP clinical and commercial manufacturing (DS/DP) and biosafety testing servicesâ€”all from a single location. With client satisfaction as our main priority, we provide highly tailored solutions using the most advanced technology to deliver product efficiently and effectively. Learn more about what we offer as well as how our multi-scale manufacturing facilities provide us with the flexibility to accommodate our clients' needs.",
            "published_at": "2020-12-08 06:32:13"
        },
        {
            "id": "VeToc8HSkpg",
            "title": "Samsung Biologics BOD Interview | John Rim",
            "description": "John Rim, EVP at Samsung Biologics, has been newly elected as an inside director at the company's 2020 Annual General Shareholder's Meeting. With rich experience and expertise from the global biopharma industry, John talks about market trends, key strengths, and the future of Samsung Biologics.",
            "published_at": "2020-05-25 05:42:08"
        },
        {
            "id": "VkWMaPGSLqU",
            "title": "Introducing Samsung Biologics Plant 4, the Super Plant",
            "description": "Following the recent groundbreaking for Plant 4, dubbed the \"Super Plant,\" the Virtual Showroom is now officially open to the public.\n\nThis dedicated page will provide real-time construction updates of the new facility as well as an in-depth introduction to specs and features Plant 4 will offer upon completion. Plant 4 will be the most ambitious and innovative project to date, breaking its own record as the world's largest and most innovative biomanufacturing facility.\n\nPlease visit our Plant 4 Virtual Showroom and learn more.\n\nhttp://www.samsungbiologics.com/plant4",
            "published_at": "2020-12-03 10:47:35"
        },
        {
            "id": "VL_-N0_KTAo",
            "title": "Our Mission | Producing Drugs of the Highest Quality",
            "description": "Over 100 million people are carrying a form of cancer worldwide, and 1 in 6 deaths occurs due to cancer globally. This World Cancer Day reminds us of our mission to bring Better Life for those suffering from this challenging disease. From cell-line development to the manufacture of biological therapies, we are pushing the boundaries of science and innovation to help our clients discover greater solutions to life-sustaining treatment.",
            "published_at": "2020-02-05 04:22:22"
        },
        {
            "id": "VmlAaUXxHEc",
            "title": "BIO Digital 2021 | The Opening Remarks in an Exclusive Keynote Session",
            "description": "Despite the fact that the global pandemic has pushed us apart in distance, it has only brought us closer together through collaboration and speed unprecedented in this industry. With the sustainability and growth of the biotech industry in mind, our vision has been, and always will be, to achieve better life through biomedicines. \n\nWatch now to hear more about our mission and future areas of expansion.",
            "published_at": "2021-08-18 10:42:54"
        },
        {
            "id": "VRSCLWJscgY",
            "title": "Accelerating Excellence, because your time saves lives",
            "description": "Developing a molecule to a new medicine is a lengthy, complex, and costly process. At Samsung Biologics, we are committed to offering high-quality products right on time because we believe time saves the lives of patients all around the globe. With our unique manufacturing capabilities and operational excellence, we promise to bring the best and provide \"Better Life\" for humanity.\n\nTo learn more about our commitment as a CMO partner, please visit us at www.samsungbiologics.com",
            "published_at": "2020-08-07 08:58:50"
        },
        {
            "id": "wAKhW8zJz1c",
            "title": "Our Story: Driven. For Growth.",
            "description": "From internship to full-time employment, we believe in fostering an environment where our employees can continuously develop and grow at all levels and stages of their career. In this month's Samsung BIO Story, Soowan Park, Senior Specialist in the Global Recruiting Group, shares how her the hands-on internship experience broadened her skillset and helped discover her career path.\n\n#SamsungBiologics #CDMO #DrivenForLife #SamsungBIOStory",
            "published_at": "2021-08-13 10:08:15"
        },
        {
            "id": "wg-L23-SdS8",
            "title": "3D Scientific Video about CDO Process Development and Capability",
            "description": "From the early stages of cell line development to clinical production, Samsung Biologics' CDO team of experts offers dedicated and flexible services for our clients at every stage of their needs. Watch the video to learn more about the journey a molecule takes to get to the market faster and better with our CDO services. We promise the best.",
            "published_at": "2020-12-02 08:20:13"
        },
        {
            "id": "WGpI39dBFDg",
            "title": "Plant 4 Construction update I Piling & Ground Leveling work",
            "description": "Since Samsung Biologics broke ground on Plant 4, the Super Plant, last year, our people have been working tirelessly to build the world's largest and most innovative bio-manufacturing facility to date. As the first phase in construction, we have meticulously undergone 'Piling & Ground Leveling' work to prepare the ground for our newest plant to strongly stand on. Check out the timelapse video of our Plant 4 site and stay tuned for more updates to come.",
            "published_at": "2021-01-25 07:33:27"
        },
        {
            "id": "WR_G6SEX68Q",
            "title": "[Highlights] CPhI WW 2019 | Speaker Session #1 | Drug Product",
            "description": "This presentation describes Samsung Biologicsâ€™ experience with Drug Product projects in clinical and commercial stages, with clientele ranging from virtual companies to big pharma. Within five years, Samsung Biologics has evolved from a single filling line start-up to an emerging competitor in the DP CDMO landscape. Focused on reinventing the customer experience, Samsung Biologics is determined to deliver where others cannot. Four case studies will be presented illustrating the adaptability and innovation Samsung Biologics has employed to successfully deliver a quality product and maintain their clientsâ€™ supply chains consistently and reliably",
            "published_at": "2019-11-07 14:19:51"
        },
        {
            "id": "wT_GnaFWerg",
            "title": "ì½”ë¦¬ì•„ ì†Œì‚¬ì´ì–´í‹° í”„ë ˆì§€ë˜íŠ¸ ì¸í„°ë·° | ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì¡´ë¦¼ ì‚¬ì¥",
            "description": "ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì˜ ì¡´ë¦¼ ì‚¬ì¥ì€ í•œë¯¸ ìƒí˜¸ê°„ì˜ ì´í•´ì™€ í˜‘ë ¥ ì¦ì§„ì„ ëª©í‘œë¡œ í•˜ëŠ” ì½”ë¦¬ì•„ ì†Œì‚¬ì´ì–´í‹°ì˜ í† ë¨¸ìŠ¤ ë²ˆ íšŒì¥ê³¼ ëŒ€ë‹´ì„ ì§„í–‰í•˜ì˜€ìŠµë‹ˆë‹¤. í•œë¯¸ ì–‘êµ­ì˜ ê¸°ì—… ë¦¬ë”ë“¤ê³¼ ê²½ì œê³„ ì „ë¬¸ê°€ë“¤ì„ ëŒ€ìƒìœ¼ë¡œ í•œë¯¸ê°„ ê²½ì œ, ê¸ˆìœµ ë° ë¹„ì¦ˆë‹ˆìŠ¤ì— ê´€í˜„ í˜„ì•ˆì„ ì§šì–´ë³´ëŠ” â€˜Presidentâ€™s Interview Seriesâ€™ í”„ë¡œê·¸ë¨ì„ í†µí•´ ì¡´ë¦¼ ì‚¬ì¥ì€ ê¸€ë¡œë²Œ ì œì•½ì‚¬ì—ì„œ ìŒ“ì€ ê²½ì˜ ë¦¬ë”ì‹­ê³¼ ë°”ì´ì˜¤ì œì•½ ì‚°ì—…ì˜ í˜„í™©ê³¼ ì „ë§, ê·¸ë¦¬ê³  ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì˜ mRNA ë°±ì‹  ìƒì‚° ì—­ëŸ‰ ë° ê¸€ë¡œë²Œ íŒ¬ë°ë¯¹ ì† ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì˜ ì—­í• ê³¼ í–¥í›„ ì„±ì¥ ë¹„ì „ ë“±ì„ ë‚˜ëˆ´ìŠµë‹ˆë‹¤. ìì„¸í•œ ë‚´ìš©ì€ ì˜ìƒì„ í†µí•´ í™•ì¸í•´ ë³´ì„¸ìš”.",
            "published_at": "2021-07-21 23:00:24"
        },
        {
            "id": "Wybqwt4F8Qs",
            "title": "2020 Samsung Biologics Annual General Meeting of Shareholders",
            "description": "On March 20th of 2020, Samsung Biologics held the Annual General Meeting\nof Shareholders and pledged to innovate its management to build a Super Value Company. Please visit our website to look at the reference materials, and further learn about our service offerings.",
            "published_at": "2020-03-24 04:28:03"
        },
        {
            "id": "xVwfHLHw_pU",
            "title": "Understanding the Alleged Samsung Biologics Accounting Issue [Episode 2]",
            "description": "This is the second of a three part video series created by Samsung Biologics to aid in the understanding of the facts regarding the alleged accounting issue.",
            "published_at": "2019-05-09 06:50:54"
        },
        {
            "id": "XWr0oeF-cpc",
            "title": "Samsung Biologics | Digital Transformation",
            "description": "At Samsung Biologics, we believe embracing digital transformation is key to demonstrating transparent and agile business operations. Watch the video and learn from Dong Soo Kang, Head of Biosafety Testing Services at Samsung Biologics, on how our CRO team defines and leverages digital solutions to enhance client satisfaction and creates more transparency and quality across all value chain.",
            "published_at": "2020-11-12 08:44:01"
        },
        {
            "id": "xZig9HzriFU",
            "title": "[V-Log] ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ JOB ë‹ë³´ê¸°â”‚ê³µì •/ê°œë°œ : Biosafety Testingí¸",
            "description": "ë‹¨ í•˜ë‚˜ì˜ ë§ˆì´ì½”í”Œë¼ìŠ¤ë§ˆ&ë°”ì´ëŸ¬ìŠ¤ë„ ìš©ì„œí•  ìˆ˜ ì—†ë‹¤! í™˜ìë“¤ì˜ ì•ˆì „ì„ ìœ„í•´ ìƒë¬¼ì•ˆì „ì‹œí—˜ì„ ìˆ˜í–‰í•˜ëŠ” Biosafety Testing Groupì˜ ê¹€ë³´ì€ í”„ë¡œ. ì—„ì²­ë‚œ ê¼¼ê¼¼í•¨ì´ ìš”êµ¬ë˜ëŠ” Biosafety Test ì—…ë¬´ì§€ë§Œ ìœ ì¾Œí•œ ë™ë£Œë“¤ê³¼ í•¨ê»˜ ë“ ë“ íˆ í•´ë‚˜ê°€ëŠ” ê¹€ë³´ì€ í”„ë¡œì˜ í•˜ë£¨ë¥¼ ì†Œê°œí•©ë‹ˆë‹¤.",
            "published_at": "2021-10-01 09:10:44"
        },
        {
            "id": "Y-0OgFD5p6g",
            "title": "[KR] BlueBetterFly \"Shaping the Future of Pharma\" Event (US)",
            "description": "BlueBetterFly. í•˜ë‚˜ì˜ ì‘ì€ ë‚ ê°œì§“ì´ ë¯¸ë˜ì˜ í° ë³€í™”ë¥¼ ê°€ì ¸ì˜¬ ìˆ˜ ìˆë‹¤ëŠ” ìš°ë¦¬ì˜ ì‹ ë…ì„ ë³´ì—¬ì£¼ëŠ” 'Shaping the Future of Pharma' ë²„ì¶”ì–¼ ë„¤íŠ¸ì›Œí‚¹ í¬ëŸ¼ì—ì„œëŠ” ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì™€ í•¨ê»˜ ì œì•½ ë°”ì´ì˜¤ ì—…ê³„ì˜ ì£¼ìš” ì „ë¬¸ê°€ë“¤ì˜ COVID-19 ê´€ë ¨ ê²¬í•´ë¥¼ ì²­ì·¨í•  ìˆ˜ ìˆëŠ” ê¸°íšŒë¥¼ ê°€ì¡ŒìŠµë‹ˆë‹¤. ì˜ìƒì„ í†µí•´ í™•ì¸ ë°”ëë‹ˆë‹¤.",
            "published_at": "2020-12-07 10:07:57"
        },
        {
            "id": "y-mzr3Im-J0",
            "title": "Samsung Biologics TRIVIA | ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ ì´ëª¨ì €ëª¨ ì•Œì•„ë³´ê¸°",
            "description": "ì†Œì†Œí•œ ì§€ì‹ì´ë‚˜ ìƒì‹ì„ ëœ»í•˜ëŠ” TRIVIA! ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì˜ ì†Œì†Œí•œ ì§€ì‹ì„ ì„ì§ì›ë“¤ì—ê²Œ ë¬¼ì–´ë³´ì•˜ìŠµë‹ˆë‹¤. ì˜ìƒ ì† í€´ì¦ˆë¥¼ í†µí•´ ì‘ì§€ë§Œ ì¤‘ìš”í•œ ì‚¼ì„±ë°”ì´ì˜¤ë¡œì§ìŠ¤ì˜ ì´ëª¨ì €ëª¨ì— ëŒ€í•´ í•¨ê»˜ ì•Œì•„ë³´ì‹¤ ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
            "published_at": "2021-07-09 12:37:37"
        },
        {
            "id": "yJrA8MXDcE0",
            "title": "Our Story: Driven. For a Better Tomorrow.",
            "description": "Starting from the ground up, we owe our success to the people who put their passion into practice every day and strive to make an impact in the world by taking on new challenges. In honor of our 10th Anniversary, we brought together two employeesâ€”Byul Choi who has been with Samsung Biologics since the beginning and Yeonha Kim who newly joinedâ€”to reflect on their experiences, how far weâ€™ve come as a company, and where they envision us going in the next decade. Discover what â€œDriven. For Life.â€ means to them at such a significant time.\n\n#SamsungBiologics #CDMO #DrivenForLife",
            "published_at": "2021-05-11 02:01:35"
        },
        {
            "id": "YPDx-RmFY6o",
            "title": "Bio Smart Board",
            "description": "Whatâ€™s the most attractive part of Samsung Biologics? Samsung Biologics promotes active communication! We induce the best results through active communication regardless of departments and positions. For example? Samsung Biologics has many channels to enhance communication among employees from various backgrounds. For example, an annual Bio Mini Olympic, Knowledge Concert, and Healing Concert. Through various cultural events Samsung Biologics strives to bring smiles to our employees. What benefits does Samsung Biologics provides to the employees? Samsung Biologics operates shuttle buses and dormitory for employees commuting from distant areas. It also operates a kindergarten for employees who have children. And it cares for employeesâ€™ health via a fitness center, hospital and pharmacy in the building. Would you recommend Samsung Biologics for career? Samsung Biologics supports career growth, happy company life, and strives to be the worldâ€™s best CMO company. I strongly recommend Samsung Biologics to you.\n\nIf you want to know more about Samsung Biologics, visit our website: https://www.samsungbiologics.com",
            "published_at": "2018-06-15 04:06:56"
        },
        {
            "id": "YTotS5-_1eo",
            "title": "Our Story: Driven. For Product Integrity.",
            "description": "As a vital part of the biopharma manufacturing process, cold chain logistics ensures that biomedicines are kept within specified temperature parameters in order to maintain its safety and effectiveness. In this month's Samsung BIO Story, Changgeun Lee, a Senior Specialist in Logistics, explains how our tightly managed, high-quality cold storage preserves the integrity of these critical products.\n\n#SamsungBiologics #CDMO #DrivenForLife #ColdChain",
            "published_at": "2021-09-08 01:06:17"
        },
        {
            "id": "Z_-c-mMOFgg",
            "title": "Get to IND Faster: Accelerated & High Performance Cell Line Development",
            "description": "Expediting development timeline is directly related to obtaining IND clearance and starting phase 1 study faster. This webinar describes how you can get to IND faster through our accelerated & high performance proprietary cell line. We will present our 3 month cell line development timeline and high quality cell line with outstanding productivity, the Faster & Better approach which can be applicable to your molecule's development path to IND.",
            "published_at": "2020-04-27 08:53:18"
        },
        {
            "id": "z-cd3v6I4l8",
            "title": "Thomas Gervais - Principal Scientist in the MSAT at Samsung Biologics",
            "description": "Thomas Gervais leads the Downstream group in the MSAT(Manufacturing Sciences and Technology) team at Samsung Biologics. Check out his interview, and find out more about working at Samsung Biologics on our Careers page at https://www.samsungbiologics.com",
            "published_at": "2019-07-12 05:14:31"
        },
        {
            "id": "ZEAxEJvqk9I",
            "title": "Samsung Biologics | Drug Product Manufacturing",
            "description": "Over the years, Samsung Biologics has been dedicated to expanding and advancing our capabilities to provide you with reliable solutions to your product supply chain needs. That's why we offer competitive drug product manufacturing with on-time, in-full delivery. From aseptic filling and lyophilization to regulatory support, discover all the clinical and commercial capabilities we have to offer.",
            "published_at": "2020-12-01 08:32:25"
        },
        {
            "id": "zf1GpYUiTlU",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        },
        {
            "id": "ZPWKD_xb2xE",
            "title": "Private video",
            "description": "This video is private.",
            "published_at": null
        }
    ]
}